The increased synthesis and release of NPY are widely reported in animal models and patients with epilepsy [30,31,32], suggesting that NPY signaling could also modulate key aspects of the cortical E/I imbalance during critical stages of ALS disease pathogenesis. Here, NPY is linked to epilepsy.